Deutsche Bank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $883M | Buy |
31,428,987
+530,139
| +2% | +$14.1M | 0.29% | 68 |
|
|
2025
Q4 | $769M | Sell |
30,898,848
-2,232,242
| -7% | -$56.3M | 0.25% | 84 |
|
|
2025
Q3 | $844M | Buy |
33,131,090
+5,009,784
| +18% | +$124M | 0.28% | 66 |
|
|
2025
Q2 | $682M | Sell |
28,121,306
-117,891
| -0.4% | -$2.75M | 0.25% | 80 |
|
|
2025
Q1 | $716M | Buy |
28,239,197
+1,846,436
| +7% | +$48.3M | 0.28% | 70 |
|
|
2024
Q4 | $700M | Sell |
26,392,761
-6,053,828
| -19% | -$164M | 0.27% | 68 |
|
|
2024
Q3 | $939M | Buy |
32,446,589
+9,809,675
| +43% | +$286M | 0.38% | 46 |
|
|
2024
Q2 | $633M | Sell |
22,636,914
-8,000,784
| -26% | -$220M | 0.29% | 69 |
|
|
2024
Q1 | $850M | Sell |
30,637,698
-9,592,030
| -24% | -$266M | 0.39% | 46 |
|
|
2023
Q4 | $1.16B | Buy |
40,229,728
+3,663,869
| +10% | +$111M | 0.59% | 23 |
|
|
2023
Q3 | $1.21B | Sell |
36,565,859
-3,686,257
| -9% | -$130M | 0.78% | 19 |
|
|
2023
Q2 | $1.48B | Buy |
40,252,116
+651,513
| +2% | +$25.4M | 0.79% | 16 |
|
|
2023
Q1 | $1.62B | Buy |
39,600,603
+2,602,964
| +7% | +$112M | 0.9% | 11 |
|
|
2022
Q4 | $1.9B | Buy |
36,997,639
+568,638
| +2% | +$27.3M | 1.09% | 11 |
|
|
2022
Q3 | $1.59B | Sell |
36,429,001
-2,703,176
| -7% | -$131M | 0.96% | 13 |
|
|
2022
Q2 | $2.05B | Buy |
39,132,177
+673,414
| +2% | +$34.3M | 1.15% | 9 |
|
|
2022
Q1 | $1.99B | Buy |
38,458,763
+4,711,484
| +14% | +$244M | 0.93% | 13 |
|
|
2021
Q4 | $1.99B | Sell |
33,747,279
-425,377
| -1% | -$21.1M | 0.9% | 15 |
|
|
2021
Q3 | $1.47B | Sell |
34,172,656
-2,266,029
| -6% | -$100M | 0.7% | 17 |
|
|
2021
Q2 | $1.43B | Buy |
36,438,685
+2,939,772
| +9% | +$114M | 0.69% | 17 |
|
|
2021
Q1 | $1.21B | Buy |
33,498,913
+858,276
| +3% | +$30.5M | 0.65% | 21 |
|
|
2020
Q4 | $1.2B | Sell |
32,640,637
-8,247,660
| -20% | -$303M | 0.73% | 21 |
|
|
2020
Q3 | $1.42B | Sell |
40,888,297
-7,679,072
| -16% | -$269M | 0.98% | 13 |
|
|
2020
Q2 | $1.51B | Buy |
48,567,369
+3,003,880
| +7% | +$102M | 1.15% | 11 |
|
|
2020
Q1 | $1.41B | Sell |
45,563,489
-6,041,638
| -12% | -$206M | 1.26% | 10 |
|
|
2019
Q4 | $1.92B | Buy |
51,605,127
+7,561,094
| +17% | +$269M | 1.25% | 9 |
|
|
2019
Q3 | $1.5B | Buy |
44,044,033
+342,576
| +0.8% | +$12.5M | 1.04% | 12 |
|
|
2019
Q2 | $1.8B | Sell |
43,701,457
-3,262,102
| -7% | -$130M | 1.05% | 10 |
|
|
2019
Q1 | $1.89B | Buy |
46,963,559
+7,175,081
| +18% | +$287M | 1.13% | 5 |
|
|
2018
Q4 | $1.65B | Sell |
39,788,478
-13,355,235
| -25% | -$554M | 1.17% | 4 |
|
|
2018
Q3 | $2.22B | Sell |
53,143,713
-3,055,090
| -5% | -$118M | 1.12% | 6 |
|
|
2018
Q2 | $1.93B | Sell |
56,198,803
-6,197,322
| -10% | -$212M | 0.96% | 8 |
|
|
2018
Q1 | $2.1B | Buy |
62,396,125
+8,177,947
| +15% | +$281M | 1% | 11 |
|
|
2017
Q4 | $1.86B | Buy |
54,218,178
+5,536,359
| +11% | +$189M | 1.19% | 3 |
|
|
2017
Q3 | $1.65B | Buy |
48,681,819
+722,665
| +2% | +$23.2M | 1.13% | 3 |
|
|
2017
Q2 | $1.53B | Buy |
47,959,154
+5,340,720
| +13% | +$168M | 1.09% | 3 |
|
|
2017
Q1 | $1.38B | Buy |
42,618,434
+1,703,379
| +4% | +$53.7M | 1.02% | 5 |
|
|
2016
Q4 | $1.26B | Sell |
40,915,055
-5,062,494
| -11% | -$155M | 1.01% | 5 |
|
|
2016
Q3 | $1.48B | Buy |
45,977,549
+2,845,261
| +7% | +$95.1M | 1.04% | 5 |
|
|
2016
Q2 | $1.44B | Sell |
43,132,288
-7,957,571
| -16% | -$254M | 1.02% | 3 |
|
|
2016
Q1 | $1.44B | Sell |
51,089,859
-5,730,775
| -10% | -$164M | 1.08% | 3 |
|
|
2015
Q4 | $1.74B | Buy |
56,820,634
+19,194,969
| +51% | +$604M | 1.2% | 3 |
|
|
2015
Q3 | $1.12B | Sell |
37,625,665
-6,216,356
| -14% | -$199M | 0.87% | 7 |
|
|
2015
Q2 | $1.39B | Sell |
43,842,021
-1,832,397
| -4% | -$59.7M | 0.89% | 5 |
|
|
2015
Q1 | $1.51B | Sell |
45,674,418
-2,917,592
| -6% | -$92.8M | 0.94% | 7 |
|
|
2014
Q4 | $1.44B | Buy |
48,592,010
+3,087,177
| +7% | +$88.5M | 0.89% | 6 |
|
|
2014
Q3 | $1.28B | Buy |
45,504,833
+1,464,217
| +3% | +$41.1M | 0.79% | 9 |
|
|
2014
Q2 | $1.24B | Sell |
44,040,616
-788,592
| -2% | -$22.5M | 0.84% | 11 |
|
|
2014
Q1 | $1.37B | Sell |
44,829,208
-1,241,014
| -3% | -$37M | 0.97% | 8 |
|
|
2013
Q4 | $1.34B | Sell |
46,070,222
-9,306,676
| -17% | -$271M | 0.96% | 7 |
|
|
2013
Q3 | $1.51B | Sell |
55,376,898
-16,428,958
| -23% | -$447M | 1.11% | 8 |
|
|
2013
Q2 | $1.91B | Buy |
+71,805,856
| New | +$1.98B | 1.56% | 2 |
|
Other funds holding PFE
VCM
VPM
Deutsche Bank's PFE Position: Q1 2026 in Review
Deutsche Bank increased its Pfizer (PFE) stake by 1.7% in Q1 2026, buying an estimated $14.1M and bringing the position to 31,428,987 shares worth $883M. The position accounts for 0.29% of the portfolio, ranked #68.
Deutsche Bank first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.22B in Q3 2018. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Deutsche Bank held 31,428,987 shares of Pfizer worth $883M as of Q1 2026.
- Deutsche Bank bought 530,139 Pfizer shares in Q1 2026, an estimated $14.1M.
- Pfizer made up 0.29% of Deutsche Bank's portfolio in Q1 2026, its #68 holding.
- Deutsche Bank first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Pfizer position peaked at $2.22B in Q3 2018.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.